Trials / Completed
CompletedNCT01618747
An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
A Single-arm, Open-label, Multicenter, Non-interventional Study to Assess Bevacizumab (Avastin) in Relapsed Glioblastoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This single-arm, open-label, multicenter, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in patients with glioblastoma multiforme in first or second relapse. Data will be collected from eligible patients initiated on Avastin treatment according to local label for up to 3 years.
Conditions
Timeline
- Start date
- 2013-03-15
- Primary completion
- 2015-12-24
- Completion
- 2015-12-24
- First posted
- 2012-06-13
- Last updated
- 2018-02-28
Locations
3 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01618747. Inclusion in this directory is not an endorsement.